The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
Partners in the COVID-19 Therapeutics Accelerator on Tuesday announced grants of USD20 million (Sh2 billion) to three institutions—the University of Washington, University of Oxford, and La Jolla Institute for Immunology—to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic.
These grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill and Melinda Gates Foundation, Wellcome, and Mastercard to speed the development of and access to therapies for COVID-19.
Premium Article
Get Full Access for Ksh299/Week.
Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Stand With Bold Journalism.
Stand With The Standard.
Journalism can't be free because the truth demands investment.
At The Standard, we invest time, courage and skills to bring you accurate,
factual and impactful stories. Subscribe today and stand with us in the
pursuit of credible journalism.